Katie Lee

Health Canada's Proposed Regulatory Amendments To Address Health Product Shortages

Supreme Court Of Canada Dismisses Apotex And Pharmascience's Applications For Leave To Appeal Paliperidone Inducing Infringement Decisions

Supreme Court Of Canada Dismisses Apotex's Application For Leave To Appeal Macitentan Inducing Infringement Decision

Federal Court Finds Patent For Concentrated Methotrexate Solutions Obvious

FCA Upholds Inducement Of Infringement Findings Relating To Paliperidone Palmitate

FCA Dismisses Appeal, Patent Not Listable Against STELARA SNDS

Federal Court Of Appeal And Federal Court Release Three Decisions Relating To Macitentan (Janssen's OPSUMIT)

PM(NOC) Regulations: Six-Year Anniversary Of Major Amendments

Minister Of Health Reasonable In Deciding Patent For Janssen's STELARA Was Ineligible For Listing Against SNDSs

FCA Finds Teva Would Directly Infringe And Induce Infringement Of Janssen's Paliperidone Palmitate Patent